Jason N Crosson1, Thomas A Swain2, Mark E Clark3, Carrie E Huisingh3, Gerald McGwin2, Cynthia Owsley3, Christine A Curcio4. 1. Retina Consultants of Alabama, Birmingham, Alabama; Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 2. Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Alabama. 3. Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 4. Department of Ophthalmology, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: christinecurcio@uabmc.edu.
Abstract
PURPOSE: OCT has revealed many details of retinal disease that were not available with older imaging technologies. In eyes of adults older than 60 years with healthy maculas as determined by color fundus photography (CFP) and a validated grading system, we screened for pathologic features using OCT. We also tested visual function to assess potential impact of the observed pathologic features on patients. DESIGN: Cross-sectional study. PARTICIPANTS: Persons recruited from primary ophthalmology care clinics. METHODS: Color fundus photographs were assessed by the 9-step Age-Related Eye Disease Study scale. OCT macular volumes of participants at step 1 on the Age-Related Eye Disease Study scale, considered healthy, were reviewed by a retina specialist masked to other participant characteristics. Participants were tested for 6 different cone- and rod-mediated visual functions. MAIN OUTCOME MEASURES: Percentage of participants with disorders detected on OCT review and visual function measures. RESULTS: In 138 of 984 eyes (14%) considered healthy by CFP, pathologic features were detectable by OCT, with 8.4% having vitreomacular interface disorders. Among the low-prevalence disorders found, 5 eyes (0.5%) showed macular telangiectasia type 2. Relative to eyes lacking detectable chorioretinal pathologic features, eyes with any pathologic features were associated with poorer low-luminance visual acuity and rod-mediated dark adaptation. In eyes with epiretinal membranes, the largest single entity identified (n = 61 [6.2%]), significantly worse visual functions were best-corrected visual acuity (P = 0.0444), low-luminance visual acuity (P = 0.0151), and light sensitivity (central 3° and 9°; P = 0.0035 and P = 0.0097, respectively). CONCLUSIONS: Macular pathologic features with functional visual implications not identified by clinical examination or CFP are detectable with OCT. Vitreomacular interface disorders often are visually significant and treatable conditions that are visible on OCT, but are easily missed on CFP and clinical examination. Another such condition best seen on OCT is macular telangiectasia type 2, an untreatable disorder for which a clinical trial is in progress. OCT has a potential role in primary eye care clinics to screen for retinal pathologic features, especially in eyes with decreased visual acuity and otherwise normal examination results.
PURPOSE:OCT has revealed many details of retinal disease that were not available with older imaging technologies. In eyes of adults older than 60 years with healthy maculas as determined by color fundus photography (CFP) and a validated grading system, we screened for pathologic features using OCT. We also tested visual function to assess potential impact of the observed pathologic features on patients. DESIGN: Cross-sectional study. PARTICIPANTS: Persons recruited from primary ophthalmology care clinics. METHODS: Color fundus photographs were assessed by the 9-step Age-Related Eye Disease Study scale. OCT macular volumes of participants at step 1 on the Age-Related Eye Disease Study scale, considered healthy, were reviewed by a retina specialist masked to other participant characteristics. Participants were tested for 6 different cone- and rod-mediated visual functions. MAIN OUTCOME MEASURES: Percentage of participants with disorders detected on OCT review and visual function measures. RESULTS: In 138 of 984 eyes (14%) considered healthy by CFP, pathologic features were detectable by OCT, with 8.4% having vitreomacular interface disorders. Among the low-prevalence disorders found, 5 eyes (0.5%) showed macular telangiectasia type 2. Relative to eyes lacking detectable chorioretinal pathologic features, eyes with any pathologic features were associated with poorer low-luminance visual acuity and rod-mediated dark adaptation. In eyes with epiretinal membranes, the largest single entity identified (n = 61 [6.2%]), significantly worse visual functions were best-corrected visual acuity (P = 0.0444), low-luminance visual acuity (P = 0.0151), and light sensitivity (central 3° and 9°; P = 0.0035 and P = 0.0097, respectively). CONCLUSIONS: Macular pathologic features with functional visual implications not identified by clinical examination or CFP are detectable with OCT. Vitreomacular interface disorders often are visually significant and treatable conditions that are visible on OCT, but are easily missed on CFP and clinical examination. Another such condition best seen on OCT is macular telangiectasia type 2, an untreatable disorder for which a clinical trial is in progress. OCT has a potential role in primary eye care clinics to screen for retinal pathologic features, especially in eyes with decreased visual acuity and otherwise normal examination results.
Authors: Daniel Shu Wei Ting; Carol Yim-Lui Cheung; Gilbert Lim; Gavin Siew Wei Tan; Nguyen D Quang; Alfred Gan; Haslina Hamzah; Renata Garcia-Franco; Ian Yew San Yeo; Shu Yen Lee; Edmund Yick Mun Wong; Charumathi Sabanayagam; Mani Baskaran; Farah Ibrahim; Ngiap Chuan Tan; Eric A Finkelstein; Ecosse L Lamoureux; Ian Y Wong; Neil M Bressler; Sobha Sivaprasad; Rohit Varma; Jost B Jonas; Ming Guang He; Ching-Yu Cheng; Gemmy Chui Ming Cheung; Tin Aung; Wynne Hsu; Mong Li Lee; Tien Yin Wong Journal: JAMA Date: 2017-12-12 Impact factor: 56.272
Authors: Peter Charbel Issa; Rob L P van der Veen; Astrid Stijfs; Frank G Holz; Hendrik P N Scholl; Tos T J M Berendschot Journal: Exp Eye Res Date: 2009-02-21 Impact factor: 3.467
Authors: Qi Sheng You; Xiao Yan Peng; Liang Xu; Chang Xi Chen; Ya Xing Wang; Jost B Jonas Journal: Ophthalmology Date: 2013-07-16 Impact factor: 12.079
Authors: Janet S Sunness; Gary S Rubin; Aimee Broman; Carol A Applegate; Neil M Bressler; Barbara S Hawkins Journal: Ophthalmology Date: 2008-05-16 Impact factor: 12.079
Authors: Roy W Beck; Pamela S Moke; Andrew H Turpin; Frederick L Ferris; John Paul SanGiovanni; Chris A Johnson; Eileen E Birch; Danielle L Chandler; Terry A Cox; R Clifford Blair; Raymond T Kraker Journal: Am J Ophthalmol Date: 2003-02 Impact factor: 5.258
Authors: Kimberly J Cocce; Sandra S Stinnett; Ulrich F O Luhmann; Lejla Vajzovic; Anupama Horne; Stefanie G Schuman; Cynthia A Toth; Scott W Cousins; Eleonora M Lad Journal: Am J Ophthalmol Date: 2018-03-15 Impact factor: 5.258
Authors: Cynthia Owsley; Mark E Clark; Carrie E Huisingh; Christine A Curcio; Gerald McGwin Journal: Invest Ophthalmol Vis Sci Date: 2016-04 Impact factor: 4.799
Authors: Benjamin S Echols; Mark E Clark; Thomas A Swain; Ling Chen; Deepayan Kar; Yuhua Zhang; Kenneth R Sloan; Gerald McGwin; Ramya Singireddy; Christian Mays; David Kilpatrick; Jason N Crosson; Cynthia Owsley; Christine A Curcio Journal: Ophthalmol Retina Date: 2020-05-07
Authors: Deepayan Kar; Mark E Clark; Thomas A Swain; Gerald McGwin; Jason N Crosson; Cynthia Owsley; Kenneth R Sloan; Christine A Curcio Journal: Invest Ophthalmol Vis Sci Date: 2020-07-01 Impact factor: 4.799
Authors: Aaron Y Lee; Cecilia S Lee; Marian S Blazes; Julia P Owen; Yelena Bagdasarova; Yue Wu; Theodore Spaide; Ryan T Yanagihara; Yuka Kihara; Mark E Clark; MiYoung Kwon; Cynthia Owsley; Christine A Curcio Journal: Transl Vis Sci Technol Date: 2020-12-15 Impact factor: 3.283